What is the role of radiotherapy after surgery in the treatment of operable stage II NSCLC?

From Cancer Guidelines Wiki
Jump to: navigation, search
Guideline contents > What is the role of radiotherapy after surgery in the treatment of operable stage II NSCLC?
Lung cancer banner.png

Information on authorship and revision

Guidelines commissioned by
Australian Government / Cancer Australia

Last modified:
21 November 2012 15:01:56

Author(s):

Professor David Ball MB BS, MD, FRANCZR. What is the role of radiotherapy after surgery in the treatment of operable stage II NSCLC? [Version URL: http://wiki.cancer.org.au/australiawiki/index.php?oldid=47735, cited 2013 May 22]. Available from http://wiki.cancer.org.au/australia/Clinical_question:What_is_the_role_of_radiotherapy_after_surgery_in_the_treatment_of_operable_stage_II_NSCLC%3F. In: Cancer Council Australia Lung Cancer Guidelines Working Party. Clinical practice guidelines for the treatment of lung cancer. Sydney: Cancer Council Australia. Available from: http://wiki.cancer.org.au/australia/Guidelines:Lung_cancer.


Contents


What is the role of radiotherapy after surgery in the treatment of operable stage II NSCLC?

Introduction

Radiotherapy either to the tumour bed or to the regional lymph nodes may be employed after surgery to reduce local recurrence, and possibly improve survival. The role of external beam radiotherapy following complete resection of NSCLC has been extensively investigated, but there is less information on the role of radiotherapy following incomplete removal of the tumour.

CCA comment button.png
Submit new evidence

Back to top

Postoperative external beam radiotherapy (PORT) versus no radiotherapy

There is strong evidence, based on an individual patient data meta-analysis and recently updated, that the use of postoperative radiotherapy following complete resection of stage II NSCLC is detrimental, and is associated with worse survival. [1]

In 718 patients with stage II disease randomised to PORT or no PORT, there was an increased risk of death with a hazard ratio was 1.24 (95% C.I.: 1.04, 1.52) in patients randomised to PORT.

CCA comment button.png
Submit new evidence

Back to top

Evidence summary and recommendations

Evidence summary Level References
Following complete resection of stage II NSCLC, the addition of adjuvant external beam radiotherapy decreases survival I [1]
Recommendation Grade
In patients who have had complete resection of stage II NSCLC, postoperative radiotherapy is not recommended. A
CCA comment button.png
Submit new evidence


Back to top

References

  1. 1.0 1.1 PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005 Apr 18;(2):CD002142 [Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/15846628].


Back to top

Appendices

Back to top
Retrieved from "http://wiki.cancer.org.au/australia/Clinical_question:What_is_the_role_of_radiotherapy_after_surgery_in_the_treatment_of_operable_stage_II_NSCLC%3F"
Personal tools
Variants
Views
Actions
Navigation
Cancer Council Australia Clinical Guidelines
Guideline Development Methodology
Australian Adult Cancer Pain Management Group
Clinical Oncological Society of Australia (COSA)
Technical issues
Toolbox
Help